title: Retinoic acid syndrome during the treatment of acute myelomonocytic leukaemia with all-trans-retinoic acid and low-dose cytosine arabinoside.
authors.forename: K
authors.initials: K
authors.lastname: Nagafuji
authors.forename: T
authors.initials: T
authors.lastname: Eto
authors.forename: Y
authors.initials: Y
authors.lastname: Tokunaga
authors.forename: S
authors.initials: S
authors.lastname: Hayashi
authors.forename: Y
authors.initials: Y
authors.lastname: Niho
mesh_terms: D003561:Cytarabine / Q000627:therapeutic use*; D006801:Humans; D015479:Leukemia, Myelomonocytic, Acute / Q000188:drug therapy*; D007958:Leukocyte Count; D007964:Leukocytosis / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D013577:Syndrome; D014212:Tretinoin / Q000009:adverse effects*
chemical_list: D003561:Cytarabine; D014212:Tretinoin